224 related articles for article (PubMed ID: 24785569)
1. Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture.
James AW; Shen J; Khadarian K; Pang S; Chung G; Goyal R; Asatrian G; Velasco O; Kim J; Zhang X; Ting K; Soo C
Tissue Eng Part A; 2014 Oct; 20(19-20):2699-710. PubMed ID: 24785569
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Tetracycline Inducible Targeting Rat PPARγ Gene Silencing on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells.
Feng X; Liu X; Cai X; Lin T; Xu W; Yang C; Liu Y; Yang S; Fu D
Curr Pharm Des; 2016; 22(41):6330-6338. PubMed ID: 27396594
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.
Sun H; Kim JK; Mortensen R; Mutyaba LP; Hankenson KD; Krebsbach PH
Stem Cells; 2013 Oct; 31(10):2183-92. PubMed ID: 23766271
[TBL] [Abstract][Full Text] [Related]
5. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
[TBL] [Abstract][Full Text] [Related]
6. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
Watt J; Schlezinger JJ
Toxicology; 2015 May; 331():66-77. PubMed ID: 25777084
[TBL] [Abstract][Full Text] [Related]
7. Impact of targeted PPARγ disruption on bone remodeling.
Cao J; Ou G; Yang N; Ding K; Kream BE; Hamrick MW; Isales CM; Shi XM
Mol Cell Endocrinol; 2015 Jul; 410():27-34. PubMed ID: 25666993
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor NKX1-2 promotes adipogenesis and may contribute to a balance between adipocyte and osteoblast differentiation.
Chen N; Schill RL; O'Donnell M; Xu K; Bagchi DP; MacDougald OA; Koenig RJ; Xu B
J Biol Chem; 2019 Nov; 294(48):18408-18420. PubMed ID: 31615896
[TBL] [Abstract][Full Text] [Related]
9. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs).
Martin PJ; Haren N; Ghali O; Clabaut A; Chauveau C; Hardouin P; Broux O
BMC Cell Biol; 2015 Mar; 16():10. PubMed ID: 25887582
[TBL] [Abstract][Full Text] [Related]
11. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
Baek K; Cho JY; Hwang HR; Kwon A; Lee HL; Park HJ; Qadir AS; Ryoo HM; Woo KM; Baek JH
J Cell Physiol; 2012 Nov; 227(11):3603-12. PubMed ID: 22307523
[TBL] [Abstract][Full Text] [Related]
12. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.
Hasegawa T; Oizumi K; Yoshiko Y; Tanne K; Maeda N; Aubin JE
BMC Dev Biol; 2008 Jul; 8():71. PubMed ID: 18625072
[TBL] [Abstract][Full Text] [Related]
13. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
14. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
[TBL] [Abstract][Full Text] [Related]
15. Reduced femoral bone mass in both diet-induced and genetic hyperlipidemia mice.
Chen X; Wang C; Zhang K; Xie Y; Ji X; Huang H; Yu X
Bone; 2016 Dec; 93():104-112. PubMed ID: 27669658
[TBL] [Abstract][Full Text] [Related]
16. PPARγ silencing enhances osteogenic differentiation of human adipose-derived mesenchymal stem cells.
Lee MJ; Chen HT; Ho ML; Chen CH; Chuang SC; Huang SC; Fu YC; Wang GJ; Kang L; Chang JK
J Cell Mol Med; 2013 Sep; 17(9):1188-93. PubMed ID: 23937351
[TBL] [Abstract][Full Text] [Related]
17. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow.
Santiago-Mora R; Casado-Díaz A; De Castro MD; Quesada-Gómez JM
Osteoporos Int; 2011 Feb; 22(2):675-84. PubMed ID: 20495905
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of peroxisome proliferator-activated receptor-γ in steroid-induced adipogenic differentiation of the bone marrow mesenchymal stem cells of rabbit using small interference RNA.
Wang Y; Li J; Liu M; Zhao G; Hao L; Li Y
Chin Med J (Engl); 2014; 127(1):130-6. PubMed ID: 24384438
[TBL] [Abstract][Full Text] [Related]
19. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
Patel JJ; Butters OR; Arnett TR
Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect Repair.
Wang C; Tanjaya J; Shen J; Lee S; Bisht B; Pan HC; Pang S; Zhang Y; Berthiaume EA; Chen E; Da Lio AL; Zhang X; Ting K; Guo S; Soo C
Am J Pathol; 2019 Mar; 189(3):648-664. PubMed ID: 30593824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
